Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000395462

Medchemexpress LLC Gepotidacin | 1075236-89-3 | 99.9% | 448.52 | 5 MG
SDP

Catalog No. 5000395462
Encompass_Preferred

Gepotidacin is a novel triazaacenaphthylene bacterial type II topoisomerase inhibitor. It is a first-in-class antibacterial that inhibits bacterial DNA gyrase and topoisomerase IV through a unique mechanism. It demonstrates in vitro activity against a broad spectrum of gram-negative and gram-positive bacteria, including drug-resistant strains.

  • Novel triazaacenaphthylene bacterial type II topoisomerase inhibitor
  • Inhibits bacterial DNA gyrase and topoisomerase IV
  • Effective against gram-negative and gram-positive bacteria
  • Active against drug-resistant bacterial strains
  • Targets pathogens associated with conventional and biothreat infections

Catalog No. 50-003-95462 Supplier Medchemexpress LLC Supplier No. HY167425MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Gepotidacin is a novel triazaacenaphthylene bacterial type II topoisomerase inhibitor. It is a first-in-class antibacterial that inhibits bacterial DNA gyrase and topoisomerase IV through a unique mechanism. It demonstrates in vitro activity against a broad spectrum of gram-negative and gram-positive bacteria, including drug-resistant strains.

  • Novel triazaacenaphthylene bacterial type II topoisomerase inhibitor
  • Inhibits bacterial DNA gyrase and topoisomerase IV
  • Effective against gram-negative and gram-positive bacteria
  • Active against drug-resistant bacterial strains
  • Targets pathogens associated with conventional and biothreat infections

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.